163 related articles for article (PubMed ID: 20035894)
1. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.
Mezzanzanica D; Bagnoli M; De Cecco L; Valeri B; Canevari S
Int J Biochem Cell Biol; 2010 Aug; 42(8):1262-72. PubMed ID: 20035894
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in ovarian cancer biology and therapy resistance.
van Jaarsveld MT; Helleman J; Berns EM; Wiemer EA
Int J Biochem Cell Biol; 2010 Aug; 42(8):1282-90. PubMed ID: 20083225
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
[TBL] [Abstract][Full Text] [Related]
5. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
6. miRNAs as molecular biomarkers of cancer.
Fabbri M
Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNAs in drug-resistant ovarian cancer cells.
Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of dicer expression in ovarian cancer tissues.
Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
Chow TF; Youssef YM; Lianidou E; Romaschin AD; Honey RJ; Stewart R; Pace KT; Yousef GM
Clin Biochem; 2010 Jan; 43(1-2):150-8. PubMed ID: 19646430
[TBL] [Abstract][Full Text] [Related]
10. Micromarkers: miRNAs in cancer diagnosis and prognosis.
Ferracin M; Veronese A; Negrini M
Expert Rev Mol Diagn; 2010 Apr; 10(3):297-308. PubMed ID: 20370587
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as prognostic markers in ovarian cancer.
Llauradó M; Majem B; Altadill T; Lanau L; Castellví J; Sánchez-Iglesias JL; Cabrera S; De la Torre J; Díaz-Feijoo B; Pérez-Benavente A; Colás E; Olivan M; Doll A; Alameda F; Matias-Guiu X; Moreno-Bueno G; Carey MS; Del Campo JM; Gil-Moreno A; Reventós J; Rigau M
Mol Cell Endocrinol; 2014 Jun; 390(1-2):73-84. PubMed ID: 24747602
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in hematological malignancies.
Fatica A; Bozzoni I
Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells.
Chen J; Wang L; Matyunina LV; Hill CG; McDonald JF
Gynecol Oncol; 2011 Apr; 121(1):200-5. PubMed ID: 21277012
[TBL] [Abstract][Full Text] [Related]
15. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
16. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in human cancer: from research to therapy.
Negrini M; Ferracin M; Sabbioni S; Croce CM
J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
[TBL] [Abstract][Full Text] [Related]
19. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R; Hussey DJ; Haier J
Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
